Half-year report · HY
4596.TEDINET S100YWOL
Period2026-01-01 → 2026-06-30
Filed2026-08-14
StandardIFRS
ConsolidatedYes
Data checks10 of 10 passed
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥8m | 2026-01-01 → 2026-06-30 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥21m | 2025-01-01 → 2025-12-31 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥13m | 2025-01-01 → 2025-06-30 | Cons. | Revenue IFRS (5-year summary) |
| Operating income | −¥650m | 2026-01-01 → 2026-06-30 | Cons. | Operating profit loss IFRS |
| Operating income | −¥450m | 2025-01-01 → 2025-06-30 | Cons. | Operating profit loss IFRS |
| Profit before tax | −¥649m | 2026-01-01 → 2026-06-30 | Cons. | Profit loss before tax IFRS |
| Profit before tax | −¥676m | 2025-01-01 → 2025-12-31 | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | −¥450m | 2025-01-01 → 2025-06-30 | Cons. | Profit loss before tax IFRS |
| Net income (owners) | −¥649m | 2026-01-01 → 2026-06-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | −¥676m | 2025-01-01 → 2025-12-31 | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | −¥450m | 2025-01-01 → 2025-06-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income | −¥649m | 2026-01-01 → 2026-06-30 | Cons. | Profit loss IFRS |
| Net income | −¥450m | 2025-01-01 → 2025-06-30 | Cons. | Profit loss IFRS |
| Total assets | ¥1.8bn | at 2026-06-30 | Cons. | Assets IFRS |
| Total assets | ¥2.0bn | at 2025-12-31 | Cons. | Assets IFRS |
| Total assets | ¥1.2bn | at 2025-06-30 | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥174m | at 2026-06-30 | Cons. | Liabilities IFRS |
| Total liabilities | ¥166m | at 2025-12-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥1.6bn | at 2026-06-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥1.8bn | at 2025-12-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥1.1bn | at 2025-06-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥1.4bn | at 2024-12-31v | Cons. | Equity IFRS |
| Equity (owners) | ¥1.6bn | at 2026-06-30 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥1.8bn | at 2025-12-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥1.1bn | at 2025-06-30 | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥1.6bn | at 2026-06-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥1.9bn | at 2025-12-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥1.1bn | at 2025-06-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥1.5bn | at 2024-12-31v | Cons. | Cash and cash equivalents IFRS |
| Operating cash flow | −¥570m | 2026-01-01 → 2026-06-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | −¥583m | 2025-01-01 → 2025-12-31 | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | −¥443m | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Investing cash flow | −¥11m | 2026-01-01 → 2026-06-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥4m | 2025-01-01 → 2025-12-31 | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | ¥2m | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Financing cash flow | ¥240m | 2026-01-01 → 2026-06-30 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | ¥1.1bn | 2025-01-01 → 2025-12-31 | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | ¥131m | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in financing activities IFRS |
| EPS (basic) | ¥-4.85 | 2026-01-01 → 2026-06-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥-10.59 | 2025-01-01 → 2025-12-31 | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥-7.71 | 2025-01-01 → 2025-06-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (diluted) | ¥-4.85 | 2026-01-01 → 2026-06-30 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥-10.59 | 2025-01-01 → 2025-12-31 | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥-7.71 | 2025-01-01 → 2025-06-30 | Cons. | Diluted earnings loss per share IFRS |
| Equity ratio | 90.2% | at 2026-06-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 91.6% | at 2025-12-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 89.6% | at 2025-06-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
All source rows · 432
| Item | Context | Value | Unit |
|---|---|---|---|
| Purchase of property plant and equipment inv cf IFRS | InterimDuration | -12288000 | JPY |
| Proceeds from collection of leasehold deposits and guarantee deposits inv cf IFRS | Prior1InterimDuration | 5117000 | JPY |
| Proceeds from collection of leasehold deposits and guarantee deposits inv cf IFRS | InterimDuration | 205000 | JPY |
| Net cash provided by used in investing activities IFRS | Prior1InterimDuration | 1819000 | JPY |
| Net cash provided by used in investing activities IFRS | InterimDuration | -10548000 | JPY |
| Proceeds from issuance of common stock fin cf IFRS | Prior1InterimDuration | 140339000 | JPY |
| Proceeds from issuance of common stock fin cf IFRS | InterimDuration | 247312000 | JPY |
| Repayments of lease obligations fin cf IFRS | Prior1InterimDuration | -9124000 | JPY |
| Repayments of lease obligations fin cf IFRS | InterimDuration | -6987000 | JPY |
| Net cash provided by used in financing activities IFRS | Prior1InterimDuration | 131215000 | JPY |
| Net cash provided by used in financing activities IFRS | InterimDuration | 240325000 | JPY |
| Effect of exchange rate changes on cash and cash equivalents IFRS | Prior1InterimDuration | -5375000 | JPY |
| Effect of exchange rate changes on cash and cash equivalents IFRS | InterimDuration | 1724000 | JPY |
| Net increase decrease in cash and cash equivalents IFRS | Prior1InterimDuration | -315089000 | JPY |
| Net increase decrease in cash and cash equivalents IFRS | InterimDuration | -338645000 | JPY |
| Cash and cash equivalents IFRS | Prior2YearInstant | 1454908000 | JPY |
| Cash and cash equivalents IFRS | Prior1YearInstant | 1918615000 | JPY |
| Cash and cash equivalents IFRS | Prior1InterimInstant | 1139819000 | JPY |
| Cash and cash equivalents IFRS | InterimInstant | 1579970000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の５第１項の表の第１号 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)関東財務局長 | |
| Filing date cover page | FilingDateInstant | 2026-08-14 | |
| Semi annual accounting period cover page | FilingDateInstant | Original text (Japanese)第12期中（自 2026年１月１日 至 2026年６月30日） | |
| Company name cover page | FilingDateInstant | Original text (Japanese)窪田製薬ホールディングス株式会社 | |
| Company name in english cover page | FilingDateInstant | Kubota Pharmaceutical Holdings Co., Ltd. | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役会長、社長兼最高経営責任者 窪田 良 | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)東京都港区南青山一丁目15番37号 | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | 03-6550-8928 | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)管理本部長 多田 卓弘 | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)東京都港区南青山一丁目15番37号 | |
| Telephone number nearest place of contact cover page | FilingDateInstant | 03-6550-8928 | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)管理本部長 多田 卓弘 | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E32854 | |
| Fund code | FilingDateInstant | － | |
| Security code | FilingDateInstant | 45960 | |
| Filer name in japanese | FilingDateInstant | Original text (Japanese)窪田製薬ホールディングス株式会社 | |
| Filer name in english | FilingDateInstant | Kubota Pharmaceutical Holdings Co., Ltd. | |
| Fund name in japanese | FilingDateInstant | － | |
| Fund name in english | FilingDateInstant | － | |
| Cabinet office ordinance | FilingDateInstant | Original text (Japanese)企業内容等の開示に関する内閣府令 | |
| Document type | FilingDateInstant | Original text (Japanese)第四号の三様式 | |
| Accounting standards | FilingDateInstant | IFRS | |
| Whether consolidated financial statements are prepared | FilingDateInstant | true | |
| Industry code when consolidated financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | CTE | |
| Industry code when financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | － | |
| Current fiscal year start date | FilingDateInstant | 2026-01-01 | |
| Current period end date | FilingDateInstant | 2026-06-30 | |
| Type of current period | FilingDateInstant | HY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 10 of 10 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |